A High-Throughput Assay for Monitoring Ubiquitination in Real Time

Overview

Journal Front Chem

Specialty Chemistry

Date 2019 Dec 24

PMID 31867306

Citations 14

Authors

Tyler G Franklin

Jonathan N Pruneda

Affiliations

Soon will be listed here.

Abstract

Protein ubiquitination is a highly orchestrated process that controls diverse aspects of human biology. Dysregulation of this process can lead to various disease states including cancer, neurodegeneration, and autoimmunity. It is the correction of these dysregulated pathways, as well as the enticing ability to manipulate protein stability, that have instigated intense research into the therapeutic control of protein ubiquitination. A major bottleneck in the development and validation of small molecule modulators is the availability of a suitable high-throughput assay for enzyme activity. Herein, we present a new assay, which we term UbiReal, that uses fluorescence polarization to monitor all stages of Ub conjugation and deconjugation in real time. We use the assay to validate a chemical inhibitor of the E1 ubiquitin-activating enzyme, as well as to assess the activities and specificities of E2s, E3s, and deubiquitinases. The sensitivity and accessibility of this approach make it an excellent candidate for high-throughput screens of activity modulators, as well as a valuable tool for basic research into the mechanisms of ubiquitin regulation.

Citing Articles

A functional screen for ubiquitin regulation identifies an E3 ligase secreted by .

Roberts C, Kaur S, Ogden A, Divine M, Warren G, Kang D bioRxiv. 2024; .

PMID: 39345563 PMC: 11430079. DOI: 10.1101/2024.09.18.613774.

Bacterial ligases reveal fundamental principles of polyubiquitin specificity.

Franklin T, Brzovic P, Pruneda J Mol Cell. 2023; 83(24):4538-4554.e4.

PMID: 38091999 PMC: 10872931. DOI: 10.1016/j.molcel.2023.11.017.

Allelic strengths of encephalopathy-associated variants correlate between in vivo and in vitro assays.

Pan X, Alvarez A, Ma M, Lu S, Crawford M, Briere L Elife. 2023; 12.

PMID: 38079206 PMC: 10712953. DOI: 10.7554/eLife.89891.

Insights into the ISG15 transfer cascade by the UBE1L activating enzyme.

Wallace I, Baek K, Prabu J, Vollrath R, von Gronau S, Schulman B Nat Commun. 2023; 14(1):7970.

PMID: 38042859 PMC: 10693564. DOI: 10.1038/s41467-023-43711-3.

Ubiquitination detection techniques.

De Silva A, Page R Exp Biol Med (Maywood). 2023; 248(15):1333-1346.

PMID: 37787047 PMC: 10625345. DOI: 10.1177/15353702231191186.

References

Gavory G, ODowd C, Helm M, Flasz J, Arkoudis E, Dossang A . Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nat Chem Biol. 2017; 14(2):118-125. DOI: 10.1038/nchembio.2528. View

Zhang , Chung , OLDENBURG . A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 2000; 4(2):67-73. DOI: 10.1177/108705719900400206. View

Clague M, Heride C, Urbe S . The demographics of the ubiquitin system. Trends Cell Biol. 2015; 25(7):417-26. DOI: 10.1016/j.tcb.2015.03.002. View

Pozhidaeva A, Valles G, Wang F, Wu J, Sterner D, Nguyen P . USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms. Cell Chem Biol. 2017; 24(12):1501-1512.e5. DOI: 10.1016/j.chembiol.2017.09.004. View

Kim H, Huibregtse J . Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol Cell Biol. 2009; 29(12):3307-18. PMC: 2698738. DOI: 10.1128/MCB.00240-09. View

Renatus M, Parrado S, DArcy A, Eidhoff U, Gerhartz B, Hassiepen U . Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure. 2006; 14(8):1293-302. PMC: 7126176. DOI: 10.1016/j.str.2006.06.012. View

Ye Y, Akutsu M, Reyes-Turcu F, Enchev R, Wilkinson K, Komander D . Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 2011; 12(4):350-7. PMC: 3077245. DOI: 10.1038/embor.2011.17. View

Hu H, Sun S . Ubiquitin signaling in immune responses. Cell Res. 2016; 26(4):457-83. PMC: 4822134. DOI: 10.1038/cr.2016.40. View

Turnbull A, Ioannidis S, Krajewski W, Pinto-Fernandez A, Heride C, Martin A . Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature. 2017; 550(7677):481-486. PMC: 6029662. DOI: 10.1038/nature24451. View

10.

Sun Y . Overview of approaches for screening for ubiquitin ligase inhibitors. Methods Enzymol. 2005; 399:654-63. DOI: 10.1016/S0076-6879(05)99043-5. View

11.

Mot A, Prell E, Klecker M, Naumann C, Faden F, Westermann B . Real-time detection of N-end rule-mediated ubiquitination via fluorescently labeled substrate probes. New Phytol. 2017; 217(2):613-624. PMC: 5763331. DOI: 10.1111/nph.14497. View

12.

Vassilev L, Vu B, Graves B, Carvajal D, Podlaski F, Filipovic Z . In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004; 303(5659):844-8. DOI: 10.1126/science.1092472. View

13.

Pickart C, Raasi S . Controlled synthesis of polyubiquitin chains. Methods Enzymol. 2005; 399:21-36. DOI: 10.1016/S0076-6879(05)99002-2. View

14.

Geurink P, van Tol B, van Dalen D, Brundel P, Mevissen T, Pruneda J . Development of Diubiquitin-Based FRET Probes To Quantify Ubiquitin Linkage Specificity of Deubiquitinating Enzymes. Chembiochem. 2016; 17(9):816-20. PMC: 4922411. DOI: 10.1002/cbic.201600017. View

15.

Foote P, Krist D, Statsyuk A . High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor. Curr Protoc Chem Biol. 2017; 9(3):174-195. PMC: 5650195. DOI: 10.1002/cpch.24. View

16.

Lamberto I, Liu X, Seo H, Schauer N, Iacob R, Hu W . Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7. Cell Chem Biol. 2017; 24(12):1490-1500.e11. PMC: 5749250. DOI: 10.1016/j.chembiol.2017.09.003. View

17.

Kategaya L, Di Lello P, Rouge L, Pastor R, Clark K, Drummond J . USP7 small-molecule inhibitors interfere with ubiquitin binding. Nature. 2017; 550(7677):534-538. DOI: 10.1038/nature24006. View

18.

Hideshima T, Richardson P, Chauhan D, Palombella V, Elliott P, Adams J . The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 2001; 61(7):3071-6. View

19.

Komander D, Rape M . The ubiquitin code. Annu Rev Biochem. 2012; 81:203-29. DOI: 10.1146/annurev-biochem-060310-170328. View

20.

Huang X, Dixit V . Drugging the undruggables: exploring the ubiquitin system for drug development. Cell Res. 2016; 26(4):484-98. PMC: 4822129. DOI: 10.1038/cr.2016.31. View